Evonik Evonik

X

CAS 4547-02-8 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 4547-02-8
Also known as: 4547-02-8, Benzp-dinitride-thio-ketone, Thionordazepam, Thionordiazepam, 7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepine-2-thione, 7-chloro-5-phenyl-1h-benzo[e]-[1,4]diazepine-2(3h)-thione
Molecular Formula
C15H11ClN2S
Molecular Weight
286.8  g/mol
InChI Key
ULILTJWAJZIROM-UHFFFAOYSA-N
FDA UNII
U953L6ZT3X

1 2D Structure

CAS 4547-02-8

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepine-2-thione
2.1.2 InChI
InChI=1S/C15H11ClN2S/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)
2.1.3 InChI Key
ULILTJWAJZIROM-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1C(=S)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3
2.2 Other Identifiers
2.2.1 UNII
U953L6ZT3X
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 4547-02-8

2. Benzp-dinitride-thio-ketone

3. Thionordazepam

4. Thionordiazepam

5. 7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepine-2-thione

6. 7-chloro-5-phenyl-1h-benzo[e]-[1,4]diazepine-2(3h)-thione

7. Demethylsulazepam

8. 7-chloro-1,3-dihydro-5-phenyl-2h-1,4-benzodiazepine-2-thione

9. Mls000546748

10. 7-chloro-5-phenyl-1,3-dihydro-2h-1,4-benzodiazepine-2-thione

11. U953l6zt3x

12. Chembl1492697

13. 7-chloro-1,3-dihydro-5-phenyl-2h-1,4-benzodiazepin-2-thione

14. Smr000113873

15. 1,3-dihydro-7-chloro-5-phenyl-2h-1,4-benzodiazepine-2-thione

16. 7-chloranyl-5-phenyl-1,3-dihydro-1,4-benzodiazepine-2-thione

17. 2h-1,4-benzodiazepine-2-thione, 7-chloro-1,3-dihydro-5-phenyl-

18. Unii-u953l6zt3x

19. Cid_826706

20. Schembl7323716

21. Schembl11530714

22. Bdbm71907

23. Dtxsid201342681

24. Hms2342p04

25. (z)-7-chloro-5-phenyl-1h-benzo[e][1,4]diazepine-2(3h)-thione

26. Bdbm50452426

27. Mfcd02068928

28. Zinc38337185

29. Akos005067468

30. Ac-8701

31. Ds-17472

32. Db-070654

33. Cs-0151398

34. Vu0474026-1

35. A51082

36. A826812

37. Ae-641/00770055

38. 7-chloro-5phenyl-3-h-1,4-benzodiazepine-2-thione

39. Q-201825

40. 1,3-dihydro-5-phenyl-7-chloro-2h-1,4-benzodiazepine-2-thione

41. 1,3-dihydro-7chloro-5phenyl-2h-1,4-benzodiazepine-2-thione

42. 7-chloro-2,3-dihydro-5-phenyl-1h-1,4-benzodiazepine-2-thione

43. 7-chloro-5-phenyl-1,3-dihydro-[1,4]benzodiazepine-2-thione

44. 7-chloro-1,3-dihydro-5-phenyl-2h-1,4-benzenodiazepine-2-thione

45. 9-chloro-6-phenyl-2.5-diazabicyclo[5.4.0]undeca-1(7),5,8,10-tetraene-3-thione

2.4 Create Date
2005-03-28
3 Chemical and Physical Properties
Molecular Weight 286.8 g/mol
Molecular Formula C15H11ClN2S
XLogP33.5
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count2
Rotatable Bond Count1
Exact Mass286.0331472 g/mol
Monoisotopic Mass286.0331472 g/mol
Topological Polar Surface Area56.5 Ų
Heavy Atom Count19
Formal Charge0
Complexity376
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag India
Digital Content Digital Content
4547-02-8
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few ...
Malladi Drugs & Pharmaceuticals Ltd was founded in 1980 by microbiologist Mr. M L N Sastry. Within a few years, Malladi established itself as a leader in manufacturing ephedrine and pseudoephedrine salts. Today, it is the leading manufacturer of APIs in the cough and cold segment. It also has a dominant presence in several therapeutic segments like antihistamines, anti-convulsants, anti-depressants and anxiolytics (CNS). Malladi exports its products to around 60 countries and over 85% of its revenue is generated from exports. Its manufacturing facilities have been approved by the FDA, EDQM, KFDA, TGA and various other regulatory agencies.
Malladi Company Banner

RDD 2024

Not Confirmed

envelop Contact Supplier
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY